| __timestamp | Amgen Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 4101058 |
| Thursday, January 1, 2015 | 4070000000 | 10763215 |
| Friday, January 1, 2016 | 3840000000 | 5579049 |
| Sunday, January 1, 2017 | 3562000000 | 32051299 |
| Monday, January 1, 2018 | 3737000000 | 24482286 |
| Tuesday, January 1, 2019 | 4116000000 | 43892589 |
| Wednesday, January 1, 2020 | 4207000000 | 44505000 |
| Friday, January 1, 2021 | 4819000000 | 79406000 |
| Saturday, January 1, 2022 | 4434000000 | 49283000 |
| Sunday, January 1, 2023 | 4784000000 | 17282730 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Amgen Inc., a giant in the biotech industry, has consistently invested heavily in R&D, with expenditures peaking at approximately $4.8 billion in 2021. This represents a steady increase of around 10% from 2014, showcasing Amgen's dedication to maintaining its leadership position.
In contrast, Verona Pharma plc, a smaller player, has shown a more volatile R&D spending pattern. Starting at just over $4 million in 2014, Verona's R&D expenses surged to nearly $79 million in 2021, marking an impressive growth of over 1800%. This dramatic increase underscores Verona's aggressive push to innovate and expand its market presence.
These trends highlight the diverse strategies employed by biotech companies in their quest for groundbreaking discoveries.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Verona Pharma plc and MannKind Corporation Allocate Funds